Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Home sweet home for Strive Physical Therapy as they expand with new location


News Image

“We are excited to announce the opening of our new clinic inside the JCC fitness center in Margate. Our patient-centered approach to physical therapy is perfectly suited to the unique needs of individuals who value their fitness and wellness..” – Erich Herkloz, Strive Physical Therapy CEO/Partner

The Milton & Betty Katz Jewish Community Center (JCC) is excited to announce they’ve partnered with Strive Physical Therapy. Effective May 2023, Strive Physical Therapy will reside on the second floor of the Katz JCC, welcoming new and existing clients to their Margate location.

“When we were looking to add a new tenant to our facility, we knew we wanted to partner with an organization that would align with our mission of serving and helping the community. We’re excited about this new partnership, and we know our community will benefit from what Strive Physical Therapy offers. We’ve already discussed collaborating on programs and events with Strive and we’re proud to be a part of their expansion,” said Marg Rosenblatt, Katz JCC CEO.

Established in 2005, Strive Physical Therapy has provided expert, compassionate care that targets their client’s root problem, resulting in lasting relief. As a physical therapist owned practice, their commitment to serving the community and helping people get better drives their work.

In the words of said Erich Herkloz, MPT, Cert. MDT and Strive Physical Therapy CEO/Partner, “We are excited to announce the opening of our new Strive Physical Therapy and Rehabilitation clinic inside the JCC fitness center in Margate. Our patient-centered approach to physical therapy is perfectly suited to the unique needs of individuals who value their fitness and wellness. With 35 locations throughout central and southern New Jersey, Pennsylvania and locally in Galloway, Northfield and Mays Landing, Strive offers a Parkinsons Program, Dizziness/Balance Program, vestibular program and sports medicine program. Strive is committed to providing the highest quality care to help our patients achieve the best possible outcomes. With our new location, we look forward to bringing our expertise and patient-centered approach to even more members of the community who are looking to take charge of their health and well-being.”

In addition to the services Erich Herkloz mentioned, Strive meets an extensive variety of client needs with their broad expertise in physical therapy treatments, including: POTS/EDS, Vertigo, Aquatic Therapy, Back/Neck Pain, Auto Accidents, Work Injuries, Pelvic Health, Neurological Conditions, Certified Hand Therapy, TMJ, Concussion, Occupational Therapy, Swim Science Center, Acupuncture and FCEs.

For more information about Strive Physical Therapy, visit them online at http://www.strivephysicaltherapy.com or call 1-800-903-4142.

###

About the JCC of Atlantic County

The mission of the Milton & Betty Katz JCC of Atlantic County is to foster an appreciation of Jewish identity, values and culture, to promote health, education and welfare of our members, to strengthen Jewish family life, to build a sense of community and ensure Jewish continuity for our children, our children’s children and ourselves.

Share article on social media or email:

SightMD Physicians named 2023 Super Doctors® and Rising Stars


“I’m honored to be selected by the committee.” said Dr. Rafailov “I feel fortunate to work with a wonderful team of doctors and support staff that help me strive in providing the best care possible for my patients.”

SightMD is excited to announce the growing list of providers that have been named on the 2023 “Super Doctor” and “Super Doctors Rising Stars” lists.

Dr. Samuel Baharestani, Dr. Jonathan Ellant, Dr. James Gordon, Dr. Faye Knoll, Dr. Michelle Liebert, Dr. Jeff Martin, and Dr. Norman Saffra were recognized as among the best in their field by the “2023 New York Super Doctors” report. The number of doctors who receive this honor is limited to approximately five percent of the region’s active physicians.

Additionally, Dr. Gaurav Chandra, Dr. Brad Kligman, Dr. Amy Mehta, Dr. Alanna Nattis, Dr. Leon Rafailov, Dr. Eric Rosenberg, Dr. Shetal Shah, and Dr. Sabah Shah were recognized as “Super Doctors Rising Stars” for having demonstrated noteworthy achievements early in their careers. The number of doctors who receive this honor is limited to approximately 2.5 percent of the region’s active physicians.

Each year, MSP Communications undertakes a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties As part of this evaluation, physicians are asked to consider the following question: “If you needed medical care in one of the following practice areas, which doctor would you choose?”

Samuel Baharestani, MD is a board certified ophthalmologist specializing in oculoplastic surgery. He treats conditions involving the eyelids, tear duct, and orbit, along with cosmetic surgery of the eyelids and eyebrows helping patients not only see better but feel bad about their appearance. “I am truly humbled to be voted a Super Doctor by my peers once again.” said Dr. Baharestani “It is an honor to provide our patients with the highest level oculoplastic surgery services at SightMD.” Dr. Baharestani has extensive training in non-surgical rejuvenation of the face with Botox, fillers, and chemical peels. As an ophthalmic plastic surgeon, he is able to combine the cosmetic principles of plastic surgery with the microsurgery of ophthalmology to achieve the best aesthetic results for his patients.

Jonathan Ellant, MD is a board certified, Fellowship-trained cataract and refractive surgeon. He believes strongly that by listening to his patients he can provide them with the best medical and surgical care possible. Dr. Jonathan Ellant has trained as a corneal specialist and performs cataract and LASIK surgeries. He utilizes the most advanced technologies available in order to deliver the best possible vision to meet the needs and desires of his patients.

James Gordon, MD is a board certified ophthalmologist and oculofacial surgeon with over 20 years of experience. He has particular expertise in the handling of challenging and complex cases involving the sensitive areas of concern around patients’ eyelids. He has published numerous papers and has given extensive lectures on ocular disease and eyelids and facial cosmetic procedures, including innovative techniques for fillers & injectables.

​​Faye Knoll, MD is a board certified ophthalmologist specializing in both laser and traditional cataract surgery as well as laser vision correction including LASIK and PRK. Dr. Knoll completed a fellowship at the New York Eye and Ear Infirmary in cornea and external diseases of the eye. Her favorite part of her job is developing lifelong relationships with her patients.

Michelle Liebert, MD is a board certified pediatric ophthalmologist specializing in strabismus surgery. Dr. Liebert takes a personal interest in each and every one of her patients, caring for each as if they were her own. One of her favorite aspects of being a doctor is that she can follow her patients from prematurity until adulthood.

Jeffrey Martin, MD is a board certified ophthalmologist and is President and Co-Founder of SightMD. Dr. Martin joined his father’s ophthalmology practice in 1997 and is proud to have helped it become a regional leader in eye care. Dr. Martin is a specialist in both LASIK and cataract surgery.

Norman A. Saffra, MD is one of the nation’s leading ophthalmic laser and microsurgeons and is known for his expertise in treating diseases that cause visual loss and had been named a castle connolly top doctor for over 25 years. Dr.Saffra is an expert in conditions affecting the posterior segment of the eye, specifically those that involve the optic nerve, or the retina and vitreous. This is the twelfth year that Dr. Saffra has been recognized as a New York “Super Doctor” putting him on the Hall of Fame list of doctors.

Gaurav Chandra, MD is a board-certified, fellowship-trained ophthalmologist who specializes in the medical management of retinal disease and uveitis. “I am grateful to be selected to the “Super Doctors Rising Stars list” for a second consecutive year,” said Dr. Chandra “This honor is a testament to the wonderful physicians and staff I have had the pleasure to work with, and the patients that have trusted us with their care.” In addition to his practice, Dr. Chandra is an assistant clinical professor at the New York Eye and Ear Infirmary where he supervises resident physicians and fellows in the uveitis clinic. Dr. Chandra is driven to provide outstanding care to patients and considers it a privilege to help improve their ocular health and sight.

Brad Kligman, MD is a board-certified ophthalmologist and fellowship-trained cornea, LASIK and cataract surgery specialist. “I am truly honored to be selected as a Super Doctors Rising Star for the 5th year in a row.” said Dr. Kligman “It is a pleasure to practice in my own community with the opportunity to care for my friends, family members and neighbors. Thanks to the support from SightMD, I am able to offer my patients the newest and greatest technologies available for optimizing vision medically and surgically.” Throughout his training, Brad Kligman, M.D. has been extensively involved in research, publishing over 20 peer-reviewed articles, textbook chapters and abstracts. He has presented his research at both national and international conferences on topics ranging from ocular tumors, to corneal collagen crosslinking (CXL) and corneal transplant techniques.

Amy Mehta, MD is a cataract surgeon and glaucoma fellowship-trained ophthalmologist. She specializes in the latest breakthroughs in cataract and glaucoma management and surgical techniques at our Rockville Center office. “I am honored to be included in such a talented group of dedicated surgeons and physicians,” said Dr. Mehta. Dr. Mehta also teaches ophthalmology residents at New York Eye and Ear Infirmary and serves as an Executive Board Member of the New York State Ophthalmological Society. Dr. Mehta has a passion for sustainable initiatives in ophthalmologic practices and serves on the Editorial Board for EyeSustain.

Alanna Nattis, DO is a cornea, cataract and refractive surgeon, as well as the Director of Clinical Research at SightMD, and an associate professor in ophthalmology and surgery at NYIT-College of Osteopathic Medicine. She is also Director of Corneal transplantation at Good Samaritan Hospital. “It is truly an honor to be nominated and included in this phenomenal and impressive group of surgeons.” said Dr. Nattis “I continue to strive for a career that will enhance my patients’ lives through their vision, as well as offer the newest and best in ophthalmic innovations available.” During residency and her fellowship, Dr. Nattis published over 15 articles in peer-reviewed journals, wrote 2 textbook chapters, and has co-authored a landmark ophthalmology textbook designed to help guide and teach surgical techniques to residents and fellows. Dr. Nattis continues to be involved in clinical research in ophthalmology and regularly presents at national specialty meetings.

Leon Rafailov, MD is a board-certified, fellowship-trained ophthalmic plastic surgeon who focuses on a wide range of plastic and reconstructive surgery in the area around the eyes. His areas of expertise include the eyelids, forehead, mid-face, orbit, and tear ducts. Dr. Rafailov takes pride in helping his patients gain confidence in seeing better and feeling better about their appearance. “I’m honored to be selected by the committee.” said Dr. Rafailov “I feel fortunate to work with a wonderful team of doctors and support staff that help me strive in providing the best care possible for my patients.” Dr. Rafailov has successfully completed thousands of surgeries in reconstructive, cosmetic, functional, and orbital surgery.

Eric Rosenberg, DO specializes in advanced corneal transplant techniques and procedures, cataract and laser vision correction surgery, as well as complex anterior segment surgery. In the last three years he has produced 25+ journal and article publications, 5 book chapters, and a full textbook used by many residents and fellows throughout the world titled “Operative Dictations in Ophthalmology”, and continues to pursue multiple research projects in the field of cornea, refractive, and external diseases. He is passionate about education in addition to the integration between technology, engineering, and medicine. Dr. Rosenberg aims not only to improve your vision in the immediate future, but to advance the field in order to improve the future vision of your entire family for decades to come.

Sabah Shah, MD is a highly skilled ophthalmologist who specializes in the medical and surgical treatment of retinal diseases. She enjoys meeting new patients and is passionate about being able to help restore vision and independence to those who need it.

Shetal Shah, MD is a board certified and fellowship trained cornea specialist and comprehensive ophthalmologist at SightMD. Dr. Shah enjoys focusing on patient education and customizing treatment plans that utilize the latest technologies to better your eye health and vision.

SightMD ophthalmologists recognized this year span the full range of care offered to the patients within the practice. Individuals on the list include professionals from the Cataract and Comprehensive Eye Care, Ophthalmic Plastic Surgery, Medical & Surgical Disease of the Retina, Pediatric Ophthalmology, Glaucoma, Cornea, Neuro-Ophthalmology services.

About SightMD

SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 80 eye care providers through the convenience of 40 locations across New York. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. For more information about SightMD, please visit https://www.sightmd.com/sightmd-ny

LynxDx President Steve Riggs Named Finalist for the Entrepreneur Of The Year® 2023 Michigan and Northwest Ohio


News Image

Steve Riggs

“It is an honor to be recognized alongside these top entrepreneurs for our work in developing diagnostic testing services to help people live healthy and productive lives.”– Steve Riggs, President, LynxDx

LynxDx, an Ann Arbor-based biotech startup and developers of the revolutionary MyProstateScore 2.0 (MPS2), announces that President Steve Riggs has been named as an Ernst & Young LLP (EY US) Entrepreneur Of The Year® 2023 Michigan and Northwest Ohio Finalist. Now in its 37th year, Entrepreneur Of The Year is one of the preeminent competitive business awards for transformative entrepreneurs and leaders of high-growth companies who are building a more equitable, sustainable, and prosperous world for all.

Riggs was selected by an independent panel of judges. Entrepreneurs were evaluated based on their demonstration of building long-term value through entrepreneurial spirit, purpose, growth, and impact, among other core contributions and attributes.

LynxDx began operations in 2020 with a focus on improving prostate cancer screening. Using a urine-based diagnostic test originated in a research lab at the University of Michigan, the company developed MyProstateScore 2.0. MPS2 is a non-invasive, data-driven, urine prostate cancer screening test that provides highly accurate, stratified risk assessment insights to guide clinical decisions for patients with elevated prostate-specific antigen (PSA) or abnormal digital rectal exam (DRE) findings. By using the MPS2 assessment, physicians are able to more accurately inform their patients whether or not a clinically relevant cancer is present, or if their elevated PSA score was the result of other factors.

“It is an honor to be recognized alongside these top entrepreneurs for our work in developing diagnostic testing services to help people live healthy and productive lives,” Riggs said. “At LynxDx, we exist to support positive public health. Prostate cancer is the most common cancer among men in the U.S. and the second leading cause of cancer death. Our MPS2 test offers a new level of simple, actionable, and data-driven decision making for both providers and patients.”

Regional EOY award winners will be announced on June 21, 2023 during a special celebration. The winners will then be considered by the national judges for the Entrepreneur Of The Year National Awards, which will be presented in November at the annual Strategic Growth Forum®, one of the nation’s most prestigious gatherings of high-growth, market-leading companies. The Entrepreneur Of The Year National Overall Award winner will then move on to compete for the World Entrepreneur Of The Year® Award in June 2024.

“This year’s finalists are the next class in an impressive line of visionaries who are leading successful, dynamic businesses. They are ambitious entrepreneurs set on transforming their industries and communities,” said Joe Lenglet, EY Partner and Entrepreneur Of The Year Michigan and Northwest Ohio program co-director.

The Entrepreneur Of The Year program has recognized more than 11,000 entrepreneurs throughout the US since its inception in 1986, and it has grown to recognize business leaders across 145 cities in over 60 countries around the world.

About LynxDx

Using technology developed at the University of Michigan, LynxDx develops innovative diagnostic solutions that can be implemented in a clinical setting. Among these are MyProstateScore™ (MPS2), a prostate cancer urine test that provides the most accurate results for prostate cancer detection and eliminates unnecessary biopsies. The company’s mission is to improve patient care through translation of cutting-edge technologies. In addition to using scientific expertise to develop novel diagnostic tools, LynxDx works to see these tools used in clinical practice. The company is committed to developing and enhancing MyProstateScore as well as looking ahead to introducing future diagnostic solutions. For more information about LynxDx and MyProstateScore™, please visit lynxdx.com.

About Entrepreneur Of The Year®

Entrepreneur Of The Year® is the world’s most prestigious business awards program for unstoppable entrepreneurs. These visionary leaders deliver innovation, growth and prosperity that transform our world. The program engages entrepreneurs with insights and experiences that foster growth. It connects them with their peers to strengthen entrepreneurship around the world. Entrepreneur Of The Year is the first and only truly global awards program of its kind. It celebrates entrepreneurs through regional and national awards programs in more than 145 cities in over 60 countries. National Overall Award winners go on to compete for the EY World Entrepreneur Of The Year™ title. Visit ey.com/us/eoy.

Share article on social media or email:

Fast-Tracking Drug Development and Scale-Up in the Post-Covid World, Upcoming Webinar Hosted by Xtalks


Join this webinar to learn how to accelerate drug development timelines in the post-Covid era.

Curia’s Approach to Rapid Scale up and Development

The webinar will focus on truncating drug development timelines in the aftermath of Covid. The featured speaker will lay emphasis on phase-appropriate development, offering creative solutions and round the clock development across various continents.

The webinar will also highlight tech transfer into various sites within the Curia network. Using a global sourcing team to find raw materials that have a diversified supply chain, the speaker will discuss how they have adapted and learnt lessons from the Covid outbreak.

Join this webinar to learn how to accelerate drug development timelines in the post-Covid era.

Join Ravi Rai, Associate Director, Chemical Development, Curia Global, Inc., for the live webinar on Tuesday, May 30, 2023, at 11:30am EDT (4:30pm BST/UK).

For more information, or to register for this event, visit Fast-Tracking Drug Development and Scale-Up in the Post-Covid World.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

New York’s Mount Sinai Health System Opens Concierge Medicine Practice in West Palm Beach


“The new Concierge Care Practice in West Palm Beach will provide comprehensive, personalized care for patients with the goal of keeping patients well and out of the hospital,” – Alicia Gresham, Senior Vice President and Chief Operating Officer of Network Practices at the Mount Sinai Health System

Mount Sinai Health System in New York, as part of its drive to bring high-quality, innovative, and dedicated care to patients in the southeast Florida area, is opening a personalized concierge care facility at 360 Rosemary in West Palm Beach, Florida.

Mount Sinai New York-Concierge Care is the third Mount Sinai facility in Florida offering access to innovative, research-driven expertise from one of New York City’s largest academic health systems. The two other Palm Beach County locations are Mount Sinai Doctors New York-Palm Beach, launched in 2018, and Mount Sinai Heart New York-Palm Beach, launched in 2015.

“With the opening of the newest Mount Sinai Health System Concierge Care facility in downtown West Palm Beach, our Health System continues to expand and to find a way to bring the best patient-centered care to Florida,” said Kenneth L. Davis, Chief Executive Officer of the Mount Sinai Health System. “Patients have choices and expect high-level medical care and access to our top-ranked specialists in New York, and this practice will meet the needs of a very savvy patient population.”

Mount Sinai New York-Concierge Care will offer two membership options—premier and premier plus—with services including 24/7 access to physicians, home visits, extended visits, telehealth appointments, cardiac assessments, annual full-body skin exams, nutrition counseling, screenings, and more. This facility will be located on the ground level of the 360 Rosemary office building at 575 Fern Street in West Palm Beach. The space will consist of 5,850 square feet and 10 exam rooms, a dermatology spa and treatment room for cosmetic procedures and hydrofacials, dermatological laser, X-ray, and ultrasound.

“Convenient access to outstanding health care is an essential component of all great neighborhoods,” said Gopal Rajegowda, Partner at Related Southeast. “Related is proud to welcome Mount Sinai New York, expanding health care offerings for those who live and work in the community, and further supporting the evolution of healthy lifestyle and longevity in downtown West Palm Beach.”

“The new Concierge Care Practice in West Palm Beach will provide comprehensive, personalized care for patients with the goal of keeping patients well and out of the hospital,” said Alicia Gresham, Senior Vice President and Chief Operating Officer of Network Practices at the Mount Sinai Health System. “As we continue to see more older adults and a growing younger demographic moving to the area who want a healthy lifestyle and longevity, we have included services to optimize health and wellness including annual cardiology assessments, pulmonary care and testing, annual skin exams, and more.”

Patients of Mount Sinai New York-Concierge Care will have access to leading Mount Sinai experts in concierge medicine, dermatology, nutrition, and cardiology to receive state-of-the-art treatment options, consultations, and personalized visits. Immediate access to specialists will be offered along with expedited access to Mount Sinai specialists in New York and a network of specialists in Palm Beach County, should patients need. Patients will also have access to a dedicated clinical team and patient navigators to coordinate care in the office, at home, or at a local hospital, as well as local events where patients can listen to Mount Sinai physicians speak on trending topics in health and wellness.

About the Mount Sinai Health System

Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.

Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report’s Best Hospitals, receiving high “Honor Roll” status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children’s Hospital among the country’s best in several pediatric specialties. For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

Predicting Immune Checkpoint Inhibitor Response Directly from Tumor RNA-Sequencing Data, Upcoming Webinar Hosted by Xtalks


There is an urgent need for robust predictive biomarkers for immune checkpoint inhibitor response to select patients with likely clinical benefit from this costly treatment.

Immune checkpoint inhibitors (ICI) have become the standard of care as a first- or second-line systemic treatment for patients with various cancer types. Unfortunately, many patients do not respond to this treatment and the occurrence of immune-related adverse events varies widely. There is an urgent need for robust predictive biomarkers for immune checkpoint inhibitor response to select patients with likely clinical benefit from this costly treatment.

Several biomarkers, aimed at predicting response to immune checkpoint inhibitors, have been proposed, including PD-L1 expression, tumor mutation burden (TMB), infiltration of cytotoxic T-cells in the tumor, Microsatellite Instability (MSI) and expression of various immune gene signatures. However, these individual biomarkers have suboptimal performance and multiple complementary omics technologies are required to properly quantify them. Integration of these multi-omic biomarkers has proven valuable in increasing the accuracy and robustness of immune checkpoint inhibitor response prediction.

The featured speakers have developed a computational pipeline that determines the expressed mutation burden (eTMB), MSI status, fraction of infiltrating immune cells and various immune gene expression signatures directly from the RNA-sequencing profile of the tumor. Each biomarker is quantified using a dedicated algorithm that applies machine learning (eTMB and MSI) or computational deconvolution (infiltrating immune cells) and integrates external data sources to maximize performance. Algorithm performance has been validated on large cohorts of tumor RNA-sequencing data with matching gold standard quantification of said biomarkers. Moreover, integrating these biomarkers improves prediction of response to checkpoint inhibition therapy.

Register for this webinar to learn how this computational approach enables the quantification of various immune checkpoint inhibitor response biomarkers from a single omics layer (RNA-seq) and improves response prediction.

Join Pieter Mestdagh, Computational Biology Manager, CellCarta, for the live webinar on Wednesday, May 31, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Predicting Immune Checkpoint Inhibitor Response Directly from Tumor RNA-Sequencing Data.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Medical Marijuana Treatment Clinics Opens as TruReleaf MD in Jackson, Mississippi


“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician.

Jackson — TruReleaf MD is expanding to Jackson, MS, as one of the state’s first medical marijuana physicians providing relief for patients through medical cannabis certifications with in-person reviews of medical conditions and medical records.

With the passage of Senate Bill 2095, Mississippi’s Medical Marijuana Program was streamlined, providing expanded medical marijuana care to patients. One of the significant provisions allows physicians to recommend medicine to patients if they believe that their patient’s qualifying debilitating medical condition would benefit from medical marijuana or that it would alleviate the symptoms of a qualifying debilitating medical condition.

TruReleaf MD comes to the state with over seven years of experience providing compassionate care in Florida as MMTCFL. Following the legalization of medical marijuana for qualifying conditions, the Medical Marijuana Treatment Clinics of Florida quickly became a pillar in the medical marijuana industry, redefining what it means to be a medical marijuana patient and providing a natural relief option to those seeking care.

With this experience, TruReleaf MD aims to restore patient quality of life through cannabis-based alternative treatments. They believe that relief is fundamental to having control over one’s life and aim to give patients the necessary tools to make the best choice for their own health.

“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician. The clinic will allow patients more opportunities to take control of their conditions, putting them one step closer to creating the life they want.

The clinic currently offers in-person appointments for those with qualifying conditions. To book an appointment, patients can visit http://www.getmymississippicard.com to schedule online or call 601-768-7944 to speak with a Patient Care Coordinator to schedule over the phone.

TruReleaf MD’s mission is to support and educate the public regarding safe access and use of medical marijuana in Mississippi. Following state guidelines, TruReleaf MD aims to simplify the process of getting a medical marijuana card and help patients take control of their care.

Share article on social media or email:

Using Machine Learning to Find High Potential Lead Molecules, Upcoming Webinar Hosted by Xtalks


Using a rapid combinatorial library and microfluidic high-throughput screening technology, it is possible to quickly design, build and screen molecular libraries to discover bioactive molecules (and inactive molecules) with quality dose-response data.

The promise of machine learning to dramatically reduce timelines in a lengthy drug discovery process is exciting, but it relies on the ability to generate a trusted set of empirical data and the continuous iteration of models.

In this webinar, the featured speakers will demonstrate their iterative and machine learning-driven discovery engine across multiple disease targets to predict novel, active chemical scaffolds and recognize SARs otherwise not identified by public data alone. Using a rapid combinatorial library and microfluidic high-throughput screening technology, it is possible to quickly design, build and screen molecular libraries to discover bioactive molecules (and inactive molecules) with quality dose-response data. This dose-response data allows library-wide SAR characterizations, empowering deep-learning QSAR model predictions and novel lead generation. The result is core starting points and activity-predictive models that expedite decision-making steps during chemical series progression.

The frontier of medicine is often fraught with early discovery decisions based on limited empirical data. While biologics discovery has been accelerated by leveraging nature’s tools for site-selective mutagenesis and rapid maturation or optimization, small molecule discovery is in desperate need of new tools that will similarly allow rapid learning cycles and optimization of clinically relevant drug properties.

In this webinar, the speakers will explore how empirical and computational platforms scout chemical space, generate measures of SAR and map the critical structural patterns to predict activity and guide development. They also explore the molecular space not previously examined and create predictions to streamline optimization toward higher potential lead molecules.

Join this webinar to learn how custom chemistry and machine learning bring medicines to patients faster.

Join experts from 1859, Ghotas Evindar, PhD, SVP Discovery; Andrew MacConnell, PhD, Cofounder and Scientific Fellow; and Hossam Ashtawy, PhD, Director of AI and ML, for the live webinar on Thursday, May 25, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Using Machine Learning to Find High Potential Lead Molecules.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Medical Marijuana Treatment Clinics Opens as TruReleaf MD in D’Iberville, Mississippi


“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician.

TruReleaf MD is expanding to D’Iberville, MS, as one of the state’s first medical marijuana physicians providing relief for patients through medical cannabis certifications with in-person reviews of medical conditions and medical records.

With the passage of Senate Bill 2095, Mississippi’s Medical Marijuana Program was streamlined, providing expanded medical marijuana care to patients. One of the significant provisions allows physicians to recommend medicine to patients if they believe that their patient’s qualifying debilitating medical condition would benefit from medical marijuana or that it would alleviate the symptoms of a qualifying debilitating medical condition.

TruReleaf MD comes to the state with over seven years of experience providing compassionate care in Florida as MMTCFL. Following the legalization of medical marijuana for qualifying conditions, the Medical Marijuana Treatment Clinics of Florida quickly became a pillar in the medical marijuana industry, redefining what it means to be a medical marijuana patient and providing a natural relief option to those seeking care.

With this experience, TruReleaf MD aims to restore patient quality of life through cannabis-based alternative treatments. They believe that relief is fundamental to having control over one’s life and aim to give patients the necessary tools to make the best choice for their own health.

“This new industry promises to offer us natural alternatives to powerful narcotics, which have caused senseless deaths of too many of our neighbors and their loved ones.” says Dr. Roberts, licensed medical marijuana physician. The clinic will allow patients more opportunities to take control of their conditions, putting them one step closer to creating the life they want.

The clinic currently offers in-person appointments for those with qualifying conditions. To book an appointment, patients can visit http://www.getmymississippicard.com to schedule online or call 601-768-7944 to speak with a Patient Care Coordinator to schedule over the phone.

TruReleaf MD’s mission is to support and educate the public regarding safe access and use of medical marijuana in Mississippi. Following state guidelines, TruReleaf MD aims to simplify the process of getting a medical marijuana card and help patients take control of their care.

Share article on social media or email:

Ideal Option Opens Addiction Medicine Clinic in El Dorado


Ideal Option, a national leader in evidence-based outpatient treatment for addiction to fentanyl, heroin, methamphetamine, alcohol and polysubstance, is now welcoming new patients in El Dorado. The new clinic, located at 625 E Main St, will provide primarily buprenorphine-based medication-assisted treatment with an onsite addiction medicine specialist.

While opioid prescribing and heroin use is on the decline, overdose deaths continue to increase in Arkansas, largely due to the prevalence of fentanyl in the illicit drug supply.

According to the Arkansas Take Back Opioid Dashboard, overdose deaths in Union County increased by 50% and narcotic arrests increased by 39% from 2020 to 2021.

Fentanyl is regularly mixed with other illicit drugs to make them more addictive, often without the user knowing. Polysubstance use disorder is therefore now the most common diagnosis at Ideal Option. According to their Annual Patient Outcomes Report for Arkansas, in 2022, over half of all Ideal Option patients tested positive for more than one substance at enrollment, and 24% tested positive for three or more substances.

The report does offer hope, however, by showing how effective medication-assisted treatment is for reducing isolated and polysubstance use. For patients who remained in treatment with Ideal Option during 2022, lab testing shows:

  • 87% less total opioid use
  • 94% less fentanyl use
  • 96% less heroin use
  • 77% less methamphetamine use
  • 90% less cocaine use

The new clinic in El Dorado is Ideal Option’s tenth location in Arkansas and is opening at a time of desperate need for expanded access to evidence-based treatment from experienced providers. Ideal Option has been specializing in addiction medicine using buprenorphine-based medications such as Suboxone® for 11 years and currently operates 90 clinics in 11 states.

“We continue to see a concerning rise in fentanyl use across Arkansas, creating an urgent demand for specialized treatment,” said Aaron Bunch, community outreach coordinator for Ideal Option. “I am excited to get to work in the great community of El Dorado to tackle this worsening crisis.”

The new Ideal Option clinic in El Dorado is open Monday – Thursday, 7:30 a.m. – 6 p.m. and is located at 625 E Main St, El Dorado, AR 71730.

Most forms of insurance are accepted, including Medicare and Medicaid, and patients can typically get started on treatment for fentanyl, heroin, alcohol or other substances within 1-3 business days.

Patients can make an appointment by calling 1.877.522.1275 or visiting http://www.idealoption.com.  

About Ideal Option 

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 65,000 patients through a network of 90 office-based medication-assisted treatment (MAT) clinics across 11 states. With a mission to serve under-served communities, Ideal Option accepts most forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available. 

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism. 

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

Share article on social media or email: